27.09.2014 Views

Program - Society of Toxicology

Program - Society of Toxicology

Program - Society of Toxicology

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Society</strong> <strong>of</strong> <strong>Toxicology</strong> 2011<br />

SOT 2011 Award Recipients<br />

Achievement Award<br />

Arnold J. Lehman Award<br />

SPECIal Events<br />

Nathan<br />

Cherrington<br />

Nathan Cherrington, Ph.D.,<br />

Associate Pr<strong>of</strong>essor <strong>of</strong> Pharmacology<br />

and <strong>Toxicology</strong>, College <strong>of</strong> Pharmacy,<br />

and Associate Pr<strong>of</strong>essor, Community<br />

Environment and Policy Division, Mel<br />

& Enid Zuckerman College <strong>of</strong> Public<br />

Health, University <strong>of</strong> Arizona, is the<br />

recipient <strong>of</strong> the SOT 2011 Achievement<br />

Award for his significant early career<br />

contributions to toxicology.<br />

Dr. Cherrington’s research focuses<br />

primarily on the role <strong>of</strong> disease<br />

states such as non-alcoholic steatohepatitis in the interindividual<br />

variability in drug metabolism and disposition.<br />

He has also extended his interest to examine the critical<br />

role that transporters play in the blood-testis barrier.<br />

Dr. Cherrington’s acclaim as an expert in transporter<br />

research has resulted in his inclusion as a member <strong>of</strong> various<br />

NIH Study Sections (NIDDK, NCCAM, XNDA, HBPP).<br />

For his studies, he has garnered support from NIH (NIDDK,<br />

NIAID, NICHD, NIEHS) and the Arizona State Disease<br />

Control Commission, as well as industrial support from<br />

AstraZeneca. The value <strong>of</strong> his research studies are further<br />

demonstrated in the competitive awards that his students<br />

have received via pre-doctoral NIH Awards and in student<br />

poster sessions at regional and national SOT meetings,<br />

including both Mechanisms and Drug Discovery <strong>Toxicology</strong><br />

Specialty Sections.<br />

Dr. Cherrington is an active member <strong>of</strong> SOT, serving on<br />

the Committee on Diversity Initiatives as well as having<br />

Regional Chapter assignments. He also serves on the<br />

Editorial Boards <strong>of</strong> Toxicological Sciences and other<br />

prominent journals in the field. He is an outstanding teacher<br />

and a prodigious author with numerous articles and a book<br />

chapter to his credit.<br />

Dr. Cherrington earned his B.S. from Brigham Young<br />

University (1993), a Ph.D. in <strong>Toxicology</strong> from North<br />

Carolina State University (1997) with Ernst Hodgson,<br />

and completed a successful postdoctoral fellowship at<br />

the University <strong>of</strong> Kansas Medical Center (2002) with<br />

Curtis Klaassen. He was recruited to the University<br />

<strong>of</strong> Arizona as an Assistant Pr<strong>of</strong>essor in 2002 where,<br />

in addition to his current responsibilities as Associate<br />

Pr<strong>of</strong>essor, he serves as the Director <strong>of</strong> the Pharmacology-<br />

<strong>Toxicology</strong> Graduate <strong>Program</strong> and as a Council member<br />

<strong>of</strong> the University’s Graduate College. For the significant<br />

contributions to toxicology that he has made in the<br />

early stages <strong>of</strong> his career, the <strong>Society</strong> <strong>of</strong> <strong>Toxicology</strong> is<br />

pleased to present the SOT 2011 Achievement Award to<br />

Dr. Nathan Cherrington.<br />

Bette Meek, Ph.D., is recognized as<br />

the 2011 Arnold J. Lehman Award<br />

recipient for her contributions to risk<br />

assessment and regulation <strong>of</strong> chemical<br />

agents.<br />

Dr. Meek is Associate Director,<br />

Chemical Risk Assessment,<br />

McLaughlin Centre for Population<br />

Health, University <strong>of</strong> Ottawa, having<br />

recently completed an Interchange<br />

Bette Meek<br />

from Health Canada, where she<br />

continues to develop opportunities for<br />

mutually beneficial interactions among the regulatory and<br />

academic communities and agencies such as the World<br />

Health Organization regarding health risk assessment, risk<br />

management, and risk communication.<br />

Widely recognized as a major driving force for the<br />

development and application <strong>of</strong> new technologies and<br />

approaches for improving the practice <strong>of</strong> human health risk<br />

assessment, Dr. Meek is especially distinguished as one <strong>of</strong><br />

the key individuals who have consistently led international<br />

efforts to move human health risk assessment forward<br />

scientifically. A prime example <strong>of</strong> her leadership has been<br />

her role in fostering the use <strong>of</strong> science-based methods<br />

including weight <strong>of</strong> evidence frameworks for incorporation<br />

<strong>of</strong> mode <strong>of</strong> action information and pharmacokinetic data and<br />

physiologically based pharmacokinetic (PBPK) modeling<br />

for determining the relationship between external exposure<br />

and internal (target tissue) exposure.<br />

A tireless, motivated, and committed contributor and<br />

leader, Dr. Meek has clearly demonstrated sustained and<br />

outstanding contributions to the knowledge and practice <strong>of</strong><br />

hazard characterization, dose response assessment, exposure<br />

assessment and risk characterization. Her efforts have led to<br />

major progress in the use <strong>of</strong> new methodologies in the health<br />

assessments conducted by Health Canada, and, through her<br />

work for national and international agencies, around the<br />

world. Among other attributes Bette is articulate, erudite,<br />

humorous, forward thinking, tenacious, and steely, making<br />

her a savvy opponent in any argument using well thought<br />

out, logical, and consistent thinking with the latest science<br />

or the appropriate application <strong>of</strong> the newer methods.<br />

Dr. Meek has moved the field <strong>of</strong> regulatory toxicology and<br />

risk assessment significantly forward though innovative<br />

thinking and principled risk assessment practice. In<br />

recognition <strong>of</strong> her achievements, the SOT Awards Committee<br />

is pleased to announce Dr. Bette Meek as the recipient <strong>of</strong> the<br />

2011 Arnold J. Lehman Award.<br />

up-to-date information at www.toxicology.org<br />

63

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!